Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, supplying promising improvements across numerous health care and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, additional trusted substitute for therapeutic use